Literature DB >> 22759388

Clinical and biopsychosocial determinants of sexual dysfunction in middle-aged and older Australian men.

Sean Martin1, Evan Atlantis, David Wilson, Kylie Lange, Matthew T Haren, Anne Taylor, Gary Wittert.   

Abstract

INTRODUCTION: Erectile dysfunction (ED) and other related sexual dysfunctions in men have recently been shown to associate with a range of conditions and biopsychosocial factors. However, few studies have been able to control for these related factors simultaneously. AIM: To determine the prevalence of and associated risk factors for ED and low solitary and dyadic sexual desire. MAIN OUTCOME MEASURES: Erectile function (International Index of Erectile Function-erectile function) and sexual desire (Sexual Desire Inventory 2), as well as associated sociodemographic, lifestyle, biological, and clinical risk factors.
METHODS: Data were collected from 1,195 randomly selected, community-dwelling men as part of the Florey Adelaide Male Ageing Study.
RESULTS: The prevalence of ED, low solitary, and dyadic sexual desire was 17.7%, 67.7%, and 13.5%, respectively. Increasing age, abdominal fat mass, obstructive sleep apnea risk, and the absence of a regular partner were associated with both degrees of ED severity. Insufficient physical activity, low alcohol consumption, and hypertension were associated with mild ED only, and voiding lower urinary tract symptoms, diabetes, and lower plasma testosterone were independently associated with moderate to severe ED. Increasing age, lower alcohol consumption, insufficient physical activity, and a diagnosis of depression, anxiety, or insomnia were associated with both low dyadic and solitary sexual desire. Postschool qualifications and lower plasma testosterone were associated with low dyadic desire, whereas lower education and income, unemployment, and migration were associated with low solitary sexual desire. The absence of a regular partner and postschool qualifications were associated with higher solitary sexual desire.
CONCLUSIONS: While ED and low dyadic and solitary sexual desire share some risk factors, we were able to demonstrate that unique factors exist for each of these domains. Attention should first be given to addressing these modifiable risk factors.
© 2012 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22759388     DOI: 10.1111/j.1743-6109.2012.02805.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

1.  Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation.

Authors:  F Lennie Wong; Liton Francisco; Kayo Togawa; Heeyoung Kim; Alysia Bosworth; Liezl Atencio; Cara Hanby; Marcia Grant; Fouad Kandeel; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

2.  Trends in reported male sexual dysfunction over the past decade: an evolving landscape.

Authors:  Edoardo Pozzi; Paolo Capogrosso; Luca Boeri; Walter Cazzaniga; Rayan Matloob; Eugenio Ventimiglia; Davide Oreggia; Nicolò Schifano; Luigi Candela; Costantino Abbate; Francesco Montorsi; Andrea Salonia
Journal:  Int J Impot Res       Date:  2020-07-01       Impact factor: 2.896

Review 3.  A systematic review of Indian studies on sexual dysfunction in patients with substance use disorders.

Authors:  Siddharth Sarkar; Nishtha Chawla; Ashlyn Tom; Prabhat Mani Pandit; Mahadev Singh Sen
Journal:  Indian J Psychiatry       Date:  2021-08-07       Impact factor: 1.759

Review 4.  Testosterone and Dehydroepiandrosterone Treatment in Ageing Men: Are We All Set?

Authors:  Andreas Walther; Julian Seuffert
Journal:  World J Mens Health       Date:  2019-06-04       Impact factor: 5.400

Review 5.  Erectile dysfunction in the elderly: an old widespread issue with novel treatment perspectives.

Authors:  Pietro Gareri; Alberto Castagna; Davide Francomano; Gregorio Cerminara; Pasquale De Fazio
Journal:  Int J Endocrinol       Date:  2014-03-17       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.